Expression and inducibility of CYP1A1, 1A2, 1B1 by β-naphthoflavone and CYP2B22, CYP3As by rifampicin in heart regions and coronary arteries of pig

Research in Veterinary Science

Volumn 94, Issue 1, 2013, Pages 77-83

  Messina, Andrea ^a   Puccinelli, Emanuela ^a   Gervasi, Pier Giovanni ^a   Longo, Vincenzo ^b  

^a CNR   (Italy)

^b Institute of Agricultural Biology and Biotechnology   (Italy)

Author keywords

Naphthoflavone; Coronary arteries; Heart; Pig CYPs; Rifampicin

Indexed keywords

BETA NAPHTHOFLAVONE; COMPLEMENTARY DNA; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2B22; CYTOCHROME P450 3A; PURINERGIC P2X RECEPTOR; RIFAMPICIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; ENZYME ACTIVITY; ENZYME INDUCTION; GENE EXPRESSION; HEART; HEART ATRIUM; HEART LEFT VENTRICLE; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE; IMMUNOBLOTTING; LIVER MICROSOME; MALE; MICROSOME; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BETA-NAPHTHOFLAVONE; CATALASE; CORONARY VESSELS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; HEART; MYOCARDIUM; REAL-TIME POLYMERASE CHAIN REACTION; RIFAMPIN; SUPEROXIDE DISMUTASE; SWINE;

SUIDAE;

EID: 84871518260     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2012.07.015     Document Type: Article

References (59)

1. Aebi, H.,1984. Catalase in vitro. (Estabrook R.W., Pulman E.E. (Eds.)), Methods in Enzymology, 105, 121-126.
2. Aboutabl M.E., Zardoky B.N.M., El-Kadi A.O.S. 3-Methylcholanthrene and benzo(a)pyrene mudulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats. British Journal of Pharmacology 2009, 158:1808-1819.
3. Bieche I., Narjoz C., Asselah T., Vacher S., Marcellin P., Liderau R., Beaune P., de Waziers I. Reverse transcriptase-PCR quantification of mRNA levels fron cytochrome CYP1, CYP2 and CYP3 families in 22 different tissues. Pharmacogenetics and Genomics 2007, 17:731-742.
4. Borlak J., Walles M., Levsen K., Thum T. Verapamil: metabolism in cultures of primary human coronary arterial endothelial cells. Drug Metabolism and Disposition 2003, 31:888-891.
5. Capdevila J.H., Harris R.C., Falck J.R. Microsomal cytochrome P450 and eicosanoid metabolism. Cellular and Molecular Life Science 2002, 59:780-789.
6. Chamberlain B.K., Levitsky D.O., Fleisher S. Isolation and characterization of canine cardiac sarcoplasmic reticulum with improved Ca++ transport properties. Journal of Biological Chemistry 1983, 258:6602-6609.
7. Chirulli V., Marvasi L., Zaghini A., Fiorio R., Longo V., Gervasi P.G. Inducibility of AhR-regulated CYP genes by beta-naphthoflavone in the liver, lung, kidney and heart of the pig. Toxicology 2007, 240:25-37.
8. Choudhary D., Jansson I., Stoilov I., Sarfarazi M., Schenkman J.B. Expression patterns of mouse and human CYP orthologous (family 1-4) during development and in different adult tissues. Archives of Biochemistry and Biophysics 2005, 436:50-61.
9. Choudhary K.R., Batchu S.N., Seubert J.M. Cytochrome P450 enzymes and the heart. IUBMB Life 2009, 61:954-960.
10. Dubey R.K., Jackson E.K., Gillespie D.G., Rosselli M., Barchiesi F., Krust A., Keller H., Zacharia L.C., Imthurn B. Cytochromes 1A1/1B1- and catechol-0-methyltransferase-derived metabolites mediate extradiol-induced antimitogenesis in human cardiac fibroblast. Journal of Clinical Endocrinology and Metabolism 2005, 90:247-255.
11. Ekins S., VandenBrandern M., Ring B., Wrighton S.A. Examination of purported probes of human CYP2B6. Pharmacogenetics 1997, 7:165-179.
12. Elbekai R.H., El-Kadi A.O. Cytochrome P450 enzymes: central players in cardiovascular health and disease. Pharmacology and Therapeutics 2006, 112:564-587.
13. Fleming I. Cytochrome P450 enzymes in vascular homeostasis. Circulation Research 2001, 89:753-762.
14. Flohe L., Gunzler W.A. Assay of glutathione peroxidase. Methods in Enzymology 1984, 105:114-121.
15. Granberg A.L., Brunstrom B., Brandt I. Cytochrome P450 dependent binding of 7,12-dimethylbenz(a)anthracene (DMBA) and Benzo(a)pyrene (B[a]P) in murine heart, lung and liver endothelial cells. Archives of Toxicology 2000, 74:593-601.
16. Granville D.J., Tashakkor B., Takeuchi C., Gustafsson A.B., Huang C., Sayen M.S., Wentworth P., Yeager M., Gottlieb R.A. Reduction of ischemia and reperfusion induced myocardial damage by cytochrome P450 inhibitors. PNAS 2003, 101:1321-1326.
17. Guengerich F.P. Human cytochrome P450 enzymes. Cytochrome P450, Structure, Mechanism and Biochemistry 2005, 377-463. Kluwer Academic/Plenum Publishers, New York. third ed. P.R. Ortiz de Montellano (Ed.).
18. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferase. The first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry 1974, 249:7130-7139.
19. Helsel D.L. Nondetects and Data Analysis: Statistics for Censored Environmental Data 2005, John Wiley and Sons, New York, pp. 250.
20. Kerzee J.K., Ramos K.S. Constitutive and inducible expression of Cyp1a1 and Cyp1b1 in vascular smooth muscle cells. Role of the Ahr bHLH/PAS transcriptional factor. Circulation Research 2001, 89:573-582.
21. Kohle C., Bock K.W. Coordinate regulation of phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. Biochemical Pharmacology 2007, 73:1853-1862.
22. Kojima M., Sekimoto M., Degawa M. A novel-gender-related difference in the constitutive expression of hepatic cytochrome P4501A subfamily enzymes in Meishan pigs. Biochemical Pharmacology 2008, 75:1076-1082.
23. Korashy H.M., El-Kadi A.O.S. The role of aryl hydrocarbon receptor in the pathogenesis of cardiovascular diseases. Drug Metabolism Reviews 2006, 38:411-450.
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
25. Longo V., Mazzaccaro A., Naldi F., Gervasi P.G. Drug metabolizing enzymes in liver, olfactory and respiratory epithelium of cattle. Journal of Biochemical Toxicology 1991, 6:123-128.
26. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
27. Lubet R.A., Mayer R.T., Cameron J.W., Nims R.W., Burke M.D., Wolf T., Guengerich F.P. Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Archives of Biochemistry and Biophysics 1985, 238:43-48.
28. Marklund S., Marklund G. Involvement of superoxide anion radical in the autooxidation of pyrogallol and convenient assay for superoxide dismutase. European Journal of Biochemistry 1974, 47:469-474.
29. McCallum G.P., Horton J.E., Falkner C.K., Bend J.R. Microsomal cytochrome P4501A1 dependent monooxygenase activity in guinea pig heart: induction, inhibition, and increased activity by addition of exogenous NADPH-cytochrome P450 reductase. Canadian Journal of Physiology and Pharmacology 1993, 71:151-156.
30. Messina A., Chirulli V., Gervasi P.G., Longo V. Purification, molecular cloning, heterologous expression and characterization of pig CYP1A2. Xenobiotica 2008, 38:1453-1470.
31. Messina A., Nannelli A., Fiorio R., Longo V., Gervasi P.G. Expression and inducibility of CYP1A1, 1A2, 1B1 by β-naphthoflavone and CYP2B22, 3A22, 3A29, 3A46 by rifampicin in the respiratory and olfactory mucosa of pig. Toxicology 2009, 260:47-52.
32. Miao W., Hu L., Scrivens J., Batist G. Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway. Journal of Biological Chemistry 2005, 280:20340-20348.
33. Michaud V., Frappier M., Dumas M.-C., Turgeon J. Metabolic activity and mRNA levels of human cardiac CYPs involved in drug metabolism. PLoS One 2010, 5:e15666.
34. Minamiyama Y., Takemura S., Akiyama T., Imaoka S., Inoue M., Funae Y., Okada S. Isoforms of cytochrome P450 on organic nitrate-derived nitric oxide release in human heart vessels. FEBS Letters 1999, 452:165-169.
35. Moore L.B., Maglich J.M., McKee D.D., Wisely B., Willson T.M., Kliewer S.A., Lambert M.H., Moore J.T. Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoato X receptor (BXR) define three pharmacologically distinct cases of nuclear receptors. Molecular Endocrinology 2002, 16:977-986.
36. 32P- Postlabeling for formation of 3-hydroxybenzo[a]pyrene and benzo[a]pyrene-3,6-quinone as major proximate genotoxic intermediates. Journal of Pharmacology and Experimental Therapeutics 2003, 305:394-401.
37. Munday R., Munday C.M. Induction of phase II enzymes by 3H-1,2-dithiole-3-thione: dose-response study in rats. Carcinogenesis 2004, 25:1721-1725.
38. Nannelli A., Chirulli V., Longo V., Gervasi P.G. Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig. Toxicology 2008, 252:105-112.
39. Nannelli A., Rossignolo F., Tolando R., Rossato P., Longo V., Gervasi P.G. Effect of β-naphthoflavone on AhR-regulated genes (CYP1A1, 1A2, 1B1, 2S1, Nrf2, and GST) and antioxidant enzymes in various brain regions of pig. Toxicology 2009, 265:69-79.
40. Nebert D.W., Roe A.L., Dieter M.Z., Solis W.A., Yang Y., Dalton T.P. Role of the aromatic hydrocarbon receptor and [Ah]gene battery in the oxidative stress response, cell cycle control and apoptosis. Biochemical Pharmacology 2000, 59:65-85.
41. Puccinelli E., Gervasi P.G., La Marca M., Beffy P., Longo V. Expression and inducibility by Phenobarbital of CYP2C33, CYP2C42, CYP2C49, CYP2B22 and CYP3As in porcine liver, kidney, small intestine and nasal tissues. Xenobiotica 2010, 40:525-535.
42. Puccinelli E., Gervasi P.G., Longo V. Xenobiotic metabolizing cytochrome P450 in pig, a promising animal model. Current Drug Metabolism 2011, 12:507-525.
43. Ramos K.S. Constitutive and inducible expression of cytochrome P4501A1 and 1B1 in human vascular endothelial and smooth muscle cells. In Vitro Cellular and Developmental Biology-Animal 1998, 34:671-673.
44. Ramos K.S., Moorthy B. Bioactivation of polycyclic aromatic hydrocarbon carcinogens within the vascular wall: implications for human atherogenesis. Drug Metabolism Reviews 2005, 37:595-610.
45. Ramadass P., Meerarani P., Toborek M., Robertson L.W., Henning B. Dietary flavonoids modulate PCB-induced oxidative stress, CYP1A1 induction, and AhR-DNA binding activity in vascular endothelial cells. Toxicology Sciences 2003, 76:212-219.
46. Raunio H., Takkola S., Pelkonen O. Regulation of CYP3A genes in the human respiratory tract. Chemical-Biological Interaction 2005, 151:53-62.
47. Sahan-Firat S., Jennings B.L., Yaghini F.A., et al. 2,3 (4,5-Thetramethoxystilbene prevents deoxycorticosterone-salt-induced hypertension: contribution of CYP1B1. American Journal of Physiology, Heart and Circulatory Physiology. 2010, 299:H1891-1901.
48. Stresser D.M., Blanchard A.P., Turner S.D., Erve J.C., Dandeneau A.A., Miller V.P., Crespi C.L. Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. Drug Metabolism and Disposition 2000, 28:1440-1448.
49. Skaanild M.T. Porcine cytochrome P450 and metabolism. Current Pharmaceutical Design 2006, 12:1421-1427.
50. Thackaberry E.A., Jang Z., Jhonson C.D., Ramos K.S., Walker M.K. Toxicogenomic profile of 2,3,7,8-tetrachorodibenzo-p-dioxin in the murine fetal heart: modulation of cell cycle and extracellular matrix genes. Toxicology Sciences 2005, 88:231-241.
51. Thum T., Borlak J. Gene expression in distinct regions of the heart. Lancet 2000, 355:979-983.
52. Thum T., Borlak J. Cytochrome P450 mono-oxygenase gene expression and protein activity in cultures of adult cardiomyocytes of the rat. British Journal of Pharmacology 2000, 130:1745-1752.
53. Thum T., Borlak J. Testosterone, cytochrome P450, and cardiac hypertrophy. FASEB Journal 2002, 16:1537-1549.
54. Towbin H.T., Staehelin P., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gel to nitrocellulose sheets: Procedure and some applications. Proceedings of the National Academy of Sciences of the United States of America 1979, 76:4350-4354.
55. Tsyrlov I.B., Goldfarb I.S., Gelboin H.V. Enzyme-kinetic and immunochemical charateristic of mouse cDNA-expressed, microsomal and purified CYP1A1 and CYP1A2. Archives of Biochemistry and Biophysics 1993, 307:259-266.
56. Waxman D.J., Halloway M.G. Sex differences in the expression of hepatic drug metabolizing enzymes. Molecular Pharmacology 2009, 76:215-228.
57. Wermuth B., Platt K.L., Scidel A., Oesch F. Carbonyl reductase provides the enzymatic basis of quinone detoxication in man. Journal of Biochemical and Molecular Toxicology 1986, 35:1277-1282.
58. Wheeler C.R., Salzman J.A., Elsayed N.M., Omayed S.T., Korte D.W. Automated assays for superoxide superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase activity. Analytical of Biochemistry 1990, 184:193-199.
59. Wortham M., Czerwinki M., He L., Parkinson A., Wan Y.-J. Expression of constitutive androstane receptor, hepatic nuclear factor 4α, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metabolism and Disposition 2007, 35:1700-1710.